Skip to main content

Advertisement

Log in

Evaluation of a preemptive intervention regimen with hesperidin methyl chalcone in delayed-onset muscle soreness in young adults: a randomized, double-blinded, and placebo-controlled trial study

  • Original Article
  • Published:
European Journal of Applied Physiology Aims and scope Submit manuscript

Abstract

Purpose

Delayed-onset muscle soreness (DOMS) describes an entity characterized by ultrastructural muscle damage. Hesperidin methyl chalcone (HMC) is a synthetic flavonoid presenting analgesic, anti-inflammatory, and antioxidant properties. We evaluated the effects of HMC upon DOMS.

Method

In a preventive paradigm, 31 sedentary young men were submitted to a randomized, double-blinded parallel trial and received HMC 500 mg or one placebo capsule × 3 days before an intense dynamic exercise protocol (concentric/eccentric actions) applied for lower limbs for inducing muscle damage. Assessments were conducted at baseline, and 24 and 48 h after, comprising physical performance, and post-muscle soreness and damage, inflammation, recovery of muscle strength, and postural balance associated with DOMS. HMC safety was also evaluated. Thirty participants completed the study.

Results

HMC improved the performance of participants during exercise (40.3 vs 51.3 repetitions to failure, p = 0.0187) and inhibited CPK levels (90.5 vs 57.9 U/L, p = 0.0391) and muscle soreness during passive quadriceps palpation (2.6 vs 1.4 VAS cm, p = 0.0439), but not during active actions, nor did it inhibit IL-1β or IL-10 levels. HMC improved muscle strength recovery, and satisfactorily refined postural balance, without inducing injury to kidneys or liver.

Conclusions

Preemptive HMC supplementation may be beneficial for boosting physical performance and for the amelioration of clinical parameters related to DOMS, including pain on muscle palpation, increased blood CPK levels, and muscle strength and proprioceptive deficits, without causing adverse effects. These data advance the understanding of the benefits provided by HMC for DOMS treatment, which supports its usefulness for such purpose.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data availability

The data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Abbreviations

1RM:

One-maximum repetition

ANOVA:

Analysis of variance

AP:

Anteroposterior

ATP:

Adenosine triphosphate

BMI:

Body mass index

COP:

Center-of-pressure

CPK:

Creatine phosphokinase

DOMS:

Delayed-onset muscle soreness

EDTA:

Ethylenediaminetetraacetic acid

IDEP:

Intense dynamic exercise protocol

EF:

Effect size

ELISA:

Enzyme-linked immunosorbent assay

EIMD:

Exercise-induced muscle damage

GGT:

Gamma glutamyl transferase

HMC:

Hesperidin methyl chalcone

IL-1β:

Interleukin-1β

IL-10:

Interleukin-10

ML:

Mediolateral

NFκB :

Nuclear factor κB

NSAIDs:

Non-steroidal anti-inflammatory drugs

PLA:

Placebo

WHO:

World Health Organization

VAS:

Visual analogue scale

References

Download references

Funding

This work was supported by grants from Fundação Nacional de Desenvolvimento do Ensino Superior Particular (FUNADESP; Grant No. 5301159) research fellowship and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) senior research fellowship (309633/2021-4). THZ and TSS received CAPES PhD bursary (finance code 001).

Author information

Authors and Affiliations

Authors

Contributions

MZL, AFA, AKSA, THZ, OKH, TSS, MMB, NAS, EOJ, WAVJ, and SMB conducted data acquisition, analysis, and interpretations. AFA, OKH, EOJ, and WAVJ contributed with reagents, analytical tools, and expert intellectual support for the study. SMB conceived and designed the study and supervised the project. MZL, WAVJ, and SMB wrote and critically revised the manuscript. All authors contributed to the content, critical review, and approved the final version of the manuscript.

Corresponding author

Correspondence to Sergio M. Borghi.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest.

Additional information

Communicated by Michael I Lindinger.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Luque, M.Z., Aguiar, A.F., da Silva-Araújo, A.K. et al. Evaluation of a preemptive intervention regimen with hesperidin methyl chalcone in delayed-onset muscle soreness in young adults: a randomized, double-blinded, and placebo-controlled trial study. Eur J Appl Physiol 123, 1949–1964 (2023). https://doi.org/10.1007/s00421-023-05207-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00421-023-05207-2

Keywords

Navigation